Evidence-based clinical review Triple Therapy for COPD: Who Benefits, Who Is at Risk for Pneumonia, and Who May Be Overtreated? A phenotype- and exacerbation-based approach to adding, continuing, or withdrawing inhaled corticosteroids Estimated reading time: 16 minutes
Tag: asthma and COPD
